BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25376843)

  • 1. UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer.
    Li SZ; Song Y; Zhang HH; Jin BX; Liu Y; Liu WB; Zhang XD; Du RL
    Sci Rep; 2014 Nov; 4():6910. PubMed ID: 25376843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference-mediated silencing of UBCH10 gene inhibits colorectal cancer cell growth in vitro and in vivo.
    Chen SM; Jiang CY; Wu JY; Liu B; Chen YJ; Hu CJ; Liu XX
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):525-9. PubMed ID: 20529090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.
    Cacciola NA; Calabrese C; Malapelle U; Pellino G; De Stefano A; Sepe R; Sgariglia R; Quintavalle C; Federico A; Bianco A; Uchimura Bastos A; Milone M; Bellevicine C; Milone F; Carlomagno C; Selvaggi F; Troncone G; Fusco A; Pallante P
    Mol Carcinog; 2016 May; 55(5):793-807. PubMed ID: 25917796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of clinicopathological features with UbcH10 expression in colorectal cancer.
    Chen S; Chen Y; Hu C; Jing H; Cao Y; Liu X
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):419-26. PubMed ID: 19779934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma.
    Bavi P; Uddin S; Ahmed M; Jehan Z; Bu R; Abubaker J; Sultana M; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Prabhakaran S; Hussain AR; Al-Kuraya KS
    Am J Pathol; 2011 May; 178(5):2109-20. PubMed ID: 21514426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
    Okamoto Y; Ozaki T; Miyazaki K; Aoyama M; Miyazaki M; Nakagawara A
    Cancer Res; 2003 Jul; 63(14):4167-73. PubMed ID: 12874022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of ubiquitin-conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro.
    Jiang L; Bao Y; Luo C; Hu G; Huang C; Ding X; Sun K; Lu Y
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):211-7. PubMed ID: 19657671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status.
    Pallante P; Malapelle U; Berlingieri MT; Bellevicine C; Sepe R; Federico A; Rocco D; Galgani M; Chiariotti L; Sanchez-Cespedes M; Fusco A; Troncone G
    Eur J Cancer; 2013 Mar; 49(5):1117-26. PubMed ID: 23102841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-conjugating enzyme UbcH10 promotes gastric cancer growth and is a potential biomarker for gastric cancer.
    Yang M; Qu Y; Shi R; Wu X; Su C; Hu Z; Chang Q; Liu S; Pan G; Lei M; Xie F; Tu S; Tao W; Zhou H; Hu G; Zhang Z
    Oncol Rep; 2016 Aug; 36(2):779-86. PubMed ID: 27349176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasis.
    Bian B; Mongrain S; Cagnol S; Langlois MJ; Boulanger J; Bernatchez G; Carrier JC; Boudreau F; Rivard N
    Mol Carcinog; 2016 May; 55(5):671-87. PubMed ID: 25808857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALLN hinders HCT116 tumor growth through Bax-dependent apoptosis.
    Li SZ; Zhang HH; Zhang JN; Zhang ZY; Zhang XF; Zhang XD; Du RL
    Biochem Biophys Res Commun; 2013 Jul; 437(2):325-30. PubMed ID: 23831472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the ubiquitin-proteasome system sensitizes TRAIL-resistant prostate cancer cells by up-regulation of death receptor 5.
    Lee YJ; Seol JW; Jeong JK; Moon MH; Park SY
    Mol Med Rep; 2011; 4(6):1255-9. PubMed ID: 21850375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UbcH10 expression in human lymphomas.
    Troncone G; Guerriero E; Pallante P; Berlingieri MT; Ferraro A; Del Vecchio L; Gorrese M; Mariotti E; Iaccarino A; Palmieri EA; Zeppa P; Palombini L; Fusco A
    Histopathology; 2009 May; 54(6):731-40. PubMed ID: 19438748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation.
    van Ree JH; Jeganathan KB; Malureanu L; van Deursen JM
    J Cell Biol; 2010 Jan; 188(1):83-100. PubMed ID: 20065091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ubiquitin-conjugating enzyme E2C/UbcH10 in astrocytic tumors.
    Jiang L; Huang CG; Lu YC; Luo C; Hu GH; Liu HM; Chen JX; Han HX
    Brain Res; 2008 Mar; 1201():161-6. PubMed ID: 18331723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOB1 is essential for the survival of RKO colorectal cancer cells.
    He XW; Feng T; Yin QL; Jian YW; Liu T
    World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin α5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker.
    Lu L; Xie R; Wei R; Cai C; Bi D; Yin D; Liu H; Zheng J; Zhang Y; Song F; Gao Y; Tan L; Wei Q; Qin H
    Mol Oncol; 2019 Dec; 13(12):2697-2714. PubMed ID: 31600854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.